...
首页> 外文期刊>AIDS reviews >Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
【24h】

Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.

机译:用于HIV-1耐药性和病毒载量测试的干血斑:对当前知识的综述和WHO对全球HIV耐药性监测的努力。

获取原文
获取原文并翻译 | 示例
           

摘要

HIV-1 drug resistance genotyping is an essential component of the World Health Organization global HIV Drug Resistance (HIVDR) prevention and assessment strategy. Plasma is considered to be the most appropriate specimen type for HIV-1 drug resistance genotyping. However, use of plasma may not be feasible in rural, remote areas in resource-limited settings since its preparation and storage requires personnel and laboratory infrastructure that is often lacking. An alternative specimen type for HIVDR genotyping is dried blood spots (DBS). DBS can be made from blood drawn for routine clinical or surveillance purposes without special laboratory processing. The filter paper used is relatively inexpensive, easily obtained and stored, and although procedures for making DBS must be followed precisely, the training required is less intensive than that required for plasma separation. HIV nucleic acids are generally stable over long periods of time and freezing is not required unless storage over two weeks is planned. In addition, DBS are more easily transported than plasma because they can be shipped as non-hazardous materials using regular mail or courier services. Many studies have reported the successful genotyping of HIV-1 from DBS and some have shown a high genotypic concordance with plasma genotypes despite potential DNA interferences. During the past few years DBS have started to be widely used for HIV-1 drug resistance testing, and an increased number of reports from resource-limited areas have indicated DBS as the preferred specimen type for transmitted HIV-1 drug resistance surveillance where plasma collection is not feasible. The World Health Organization has brought together a group of experts (WHO HIVResNet DBS working group) to review current data on DBS preparation, storage, and transport conditions, and provide a reference protocol, which is also summarized in this article.
机译:HIV-1耐药性基因分型是世界卫生组织全球HIV耐药性(HIVDR)预防和评估策略的重要组成部分。血浆被认为是最适合HIV-1耐药基因分型的标本类型。但是,在资源有限的农村偏远地区,血浆的使用可能不可行,因为血浆的制备和存储需要经常缺乏的人员和实验室基础设施。 HIVDR基因分型的另一种标本类型是干血斑(DBS)。 DBS可以从用于常规临床或监测目的的血液中提取,无需特殊的实验室处理。所使用的滤纸相对便宜,易于获得和存储,尽管必须严格遵循制造DBS的程序,但所需的训练强度不如血浆分离所需的强度。 HIV核酸通常可以长时间稳定,除非计划储存两周以上,否则不需要冷冻。此外,与等离子相比,DBS的运输更容易,因为它们可以使用常规邮件或快递服务作为无害材料运输。许多研究已经报道了来自星展银行(DBS)的HIV-1成功的基因分型,尽管有潜在的DNA干扰,但一些研究显示与血浆基因型高度一致。在过去的几年中,DBS已开始广泛用于HIV-1耐药性检测,并且越来越多的资源有限地区的报告表明,DBS是进行HIV-1耐药性监测的首选标本类型,其中血浆收集不可行。世界卫生组织召集了一个专家组(WHO HIVResNet DBS工作组)来审查有关DBS制备,储存和运输条件的当前数据,并提供参考协议,本文对此也进行了概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号